A diverse team with a strong track record

Management team

 
Dr Suzanne Saffie-Siebert
Chairwoman & Chief Executive Officer

I believe good science equals good business. SiSaf is the culmination of more than 25 years that I spent in drug delivery research and senior management.

Linked In
plus
 
Dr Paul Jenkins
Chief Commercial Officer

With more than 20 years of senior management and business development roles in drug delivery, SiSaf stands out because it not only licenses its technology – it also develops its own products.

Linked In
plus
 
Dr Michael Welsh
Chief Scientific Officer

As an immunologist, I spent two decades understanding the modes of action in disease and looking for treatments. I’ve seen how ProSilic bio-courier technology can intervene and cure.

Linked In
plus
 
Dr Nessim Torabi-Pour
Chief Technical Officer

My 20 years’ experience in analytical techniques and drug delivery research helped boost the development of ProSilic  right from the start.

Linked In
plus
 
Charles Weatherstone
Chief Marketing Officer

Over my many years in health care marketing I’ve had lots of drug delivery systems cross my desk but all of them fell short, until I was introduced to SiSaf. I was so impressed I joined the company.

Linked In
plus
 
Chris Gilmour
Head of Manufacture & Supply

Applying  my technical experience from blue chip pharma companies to  SiSaf  has delivered rapid scale up and manufacturing capability for our ever increasing pipeline.

Linked In
plus

Board

 
Dr Suzanne Saffie-Siebert
Chairwoman & Chief Executive Officer

I believe good science equals good business. SiSaf is the culmination of more than 25 years that I spent in drug delivery research and senior management.

Linked In
plus
 
Dr. Elkhalil Binebine
Board Member

I led the Series A investment in SiSaf not just because of their innovative platform technology, but also the passion of the people behind it.

plus
 
Dr Damian Kelly
Board Member

As Croda’s Head of Global R&D, I value the  expertise and dedication that SiSaf’s team bring to their breakthrough technology.

Linked In
plus
 
Dr Finian Tan
Board Member

Ever since I led the investment in Baidu and became its largest shareholder on behalf of Dfj Eplanet, I’ve been on the lookout for companies with game changing technologies. SiSaf is one of those game changers.

Linked In
plus
 
Eric M. Attias
Board Member

During my 25 years in the financial industry, SiSaf is one of the most exciting biotech companies I’ve come across.

Linked In
plus
 
Neil Simms
Board Member

I’m extremely  proud to have spotted the company’s global potential in its early days.

Linked In
plus
 
Tim Brundle
Board Member

As Director of Research and Impact for one of SiSaf’s first investors, I’ve followed the company’s extraordinary progress from day one.

Linked In
plus